Fast and efficient healing of scleroderma-associated acral ulcers with sildenafil;Rasche abheilung von akralen ulzera bei systemischer sklerodermie unter sildenafil

Hautarzt

Volumn 59, Issue 3, 2008, Pages 230-232

  Friedrichson, E ^a   Rehberger, P ^a   Fuhrmann, J T ^a   Walz, F ^a   Meurer, M ^a   Pfeiffer, C ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Acral ulcers; Inhibitors of phosphodiesterase 5; Pulmonary arterial hypertension; Sildenafil; Systemic sclerosis

Indexed keywords

CYCLIC GMP; PHOSPHODIESTERASE V INHIBITOR; SILDENAFIL;

ACRAL ULCER; ADULT; ARTERY DILATATION; CASE REPORT; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG MECHANISM; DYSPNEA; HUMAN; MALE; PULMONARY HYPERTENSION; SCLERODERMA; SHORT SURVEY; SYSTEMIC SCLEROSIS; ULCER; WALKING; WOUND HEALING;

ADULT; EXTREMITIES; HUMANS; MALE; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; PURINES; SCLERODERMA, SYSTEMIC; SULFONES; TREATMENT OUTCOME; WOUND HEALING;

EID: 40549132604     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-007-1366-1     Document Type: Short Survey

References (12)

1. Colglazier CL, Sutej PG, O'Rourke KS (2005) Severe refractory fingertip ulcerations in a patient with scleroderma: successful treatment with sildenafil. J Rheumatol 32: 2440-2442
2. Fries R, Shariat K, von Wilmowsky H, Böhm M (2005) Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy. Circulation 112: 2980-2985
3. Galie N, Ghofrani HA, Torbicki A et al. (2005) Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med (United States) 353(20): 2148-2157
4. Ghofrani HA, Rose F, Schermuly RT et al. (2003) Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension. J Am Coll Cardiol 42: 158-164
5. Kamata Y, Kamimura T, Iwamoto M et al. (2005) Comparable effects of sildenafil citrate and alprostadil on severe Raynaud's phenomenon in a patient with systemic sclerosis. Clin Exp Dermatol 30: 451
6. Koh ET, Lee P, Gladman DD et al. (1996) Pulmonary hypertension in systemic sclerosis: an analysis of 17 patients. Br J Rheumatol 35: 989-993
7. Matucci CM, Kahaleh MB (2002) Beauty and the beast. The nitric oxide paradox in systemic sclerosis. Rheumatol Oxford 41: 843-847
8. Pfister R, Erdmann E, Schneider CA (2003) Die natriuretischen Peptide BNP und NT-pro-BNP - die.,neuen Troponine"der Herzinsuffizienz? Dtsch Med Wochenschr 128: 1007-1012
9. Rich S, Dantzker DR, Ayres SM et al (1987) Primary pulmonary hypertension. A national prospective study. Ann Internal Med 107: 216-223
10. Rosenkranz S, Caglayan E, Diet F et al. (2004) Langzeiteffekte von Sildenafil bei Sklerodermie-assoziierter pulmonaler Hypertonie und Raynaud-Syndrom. Dtsch Med Wochenschr 129: 1736-1740
11. Schmiedeberg S von, Artik S, Assmann T et al. (2004) Behandlung therapieresistenter akraler Ulzera mit Iloprost. Hautarzt 55: 1150-1153
12. Sunderkötter C, Riemekasten G (2006) Raynaud-Phänomen in der Dermatologie. Hautarzt 57: 927-942